These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 29684595)

  • 1. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
    Kuba K; Sato T; Imai Y; Yamaguchi T
    Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
    Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
    Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The functional role of endogenous APJ agonists; Apelin and Elabela/Toddler in cardiovascular diseases].
    Sato T; Kuba K
    Nihon Yakurigaku Zasshi; 2019; 153(4):172-178. PubMed ID: 30971657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological functions of Elabela, a novel endogenous ligand of APJ receptor.
    Xu J; Chen L; Jiang Z; Li L
    J Cell Physiol; 2018 Sep; 233(9):6472-6482. PubMed ID: 29350399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction.
    Chen J; Chen X; Li S; Jiang Y; Mao H; Zhang R; Ji B; Yan M; Cai X; Wang C
    Redox Biol; 2020 Sep; 36():101629. PubMed ID: 32863206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia.
    Liu Y; Wang L; Shi H
    Hypertens Res; 2019 Jul; 42(7):928-934. PubMed ID: 30626933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The apelin/APJ system in the regulation of vascular tone: friend or foe?
    Rikitake Y
    J Biochem; 2021 Apr; 169(4):383-386. PubMed ID: 33169143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.
    Read C; Nyimanu D; Williams TL; Huggins DJ; Sulentic P; Macrae RGC; Yang P; Glen RC; Maguire JJ; Davenport AP
    Pharmacol Rev; 2019 Oct; 71(4):467-502. PubMed ID: 31492821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elabela/Toddler and apelin bind differently to the apelin receptor.
    Couvineau P; Llorens-Cortes C; Iturrioz X
    FASEB J; 2020 Jun; 34(6):7989-8000. PubMed ID: 32301550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling.
    Deng C; Chen H; Yang N; Feng Y; Hsueh AJ
    J Biol Chem; 2015 Jul; 290(30):18261-8. PubMed ID: 25995451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
    Huang Z; He L; Chen Z; Chen L
    J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension.
    Song J; Tang J; Zhang Z; Liu Y; Zhong J
    Chin Med J (Engl); 2022 May; 135(9):1019-1026. PubMed ID: 34608073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential Role of the ELABELA-APJ Signaling Pathway in Cardiovascular System Development and Diseases.
    Zhou S; Wang J; Wang Q; Meng Z; Peng J; Song W; Zhou Y; Chen S; Chen F; Sun K
    J Cardiovasc Pharmacol; 2020 Apr; 75(4):284-291. PubMed ID: 32000202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of apelin and Elabela in cardiovascular disease.
    Gao S; Chen H
    Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Study of Elabela and Apelin on Apelin Receptor Activation Through β-Arrestin Recruitment.
    Zhang H; Chen J; Shi M; Xu F; Zhang X; Gong DW
    Mol Biotechnol; 2023 Mar; 65(3):394-400. PubMed ID: 35960440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles.
    Jiang Y; Yan M; Wang C; Wang Q; Chen X; Zhang R; Wan L; Ji B; Dong B; Wang H; Chen J
    Front Pharmacol; 2021; 12():630548. PubMed ID: 33746758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin/ELABELA-APJ system in cardiac hypertrophy: Regulatory mechanisms and therapeutic potential.
    Pang B; Jiang YR; Xu JY; Shao DX; Hao LY
    Eur J Pharmacol; 2023 Jun; 949():175727. PubMed ID: 37062502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling.
    Sato T; Kadowaki A; Suzuki T; Ito H; Watanabe H; Imai Y; Kuba K
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Elabela-APJ axis: a promising therapeutic target for heart failure.
    Ma Z; Song JJ; Martin S; Yang XC; Zhong JC
    Heart Fail Rev; 2021 Sep; 26(5):1249-1258. PubMed ID: 32314083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Apela Peptide in Mice Causes Low Penetrance Embryonic Lethality and Defects in Early Mesodermal Derivatives.
    Freyer L; Hsu CW; Nowotschin S; Pauli A; Ishida J; Kuba K; Fukamizu A; Schier AF; Hoodless PA; Dickinson ME; Hadjantonakis AK
    Cell Rep; 2017 Aug; 20(9):2116-2130. PubMed ID: 28854362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.